[1]
A. P. Sayani, “Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada”, CUAJ, vol. 8, no. 1-2, pp. e1–7, Jan. 2014.